| Autor: |
Miller, Jeffrey C., Patil, Deepak P., Xia, Danny F., Paine, Charles B., Fauser, Friedrich, Richards, Hunter W., Shivak, David A., Bendaña, Yuri R., Hinkley, Sarah J., Scarlott, Nicholas A., Lam, Stephen C., Reik, Andreas, Zhou, Yuanyue, Paschon, David E., Li, Patrick, Wangzor, Tenzin, Lee, Gary, Zhang, Lei, Rebar, Edward J. |
| Zdroj: |
Nature Biotechnology; Aug2019, Vol. 37 Issue 8, p945-952, 8p, 2 Diagrams, 1 Chart, 1 Graph |
| Abstrakt: |
Engineered nucleases have gained broad appeal for their ability to mediate highly efficient genome editing. However the specificity of these reagents remains a concern, especially for therapeutic applications, given the potential mutagenic consequences of off-target cleavage. Here we have developed an approach for improving the specificity of zinc finger nucleases (ZFNs) that engineers the FokI catalytic domain with the aim of slowing cleavage, which should selectively reduce activity at low-affinity off-target sites. For three ZFN pairs, we engineered single-residue substitutions in the FokI domain that preserved full on-target activity but showed a reduction in off-target indels of up to 3,000-fold. By combining this approach with substitutions that reduced the affinity of zinc fingers, we developed ZFNs specific for the TRAC locus that mediated 98% knockout in T cells with no detectable off-target activity at an assay background of ~0.01%. We anticipate that this approach, and the FokI variants we report, will enable routine generation of nucleases for gene editing with no detectable off-target activity. Engineered zinc finger nucleases achieve 98% knockout of a target gene in human T cells without detectable off-target activity. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink